Related Experiment Video
Updated: Jun 19, 2026
11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Metabolomics: moving towards personalized medicine.
Eugenio Baraldi1, Silvia Carraro, Giuseppe Giordano
1Department of Pediatrics, University of Padova, Padua, Italy. baraldi@pediatria.unipd.it.
Italian Journal of Pediatrics
|October 27, 2009
Summary
Metabolomics offers a powerful approach to understanding pediatric diseases at a molecular level. This technique analyzes metabolic fingerprints to personalize treatments and predict drug responses in children.
Area of Science:
- Biomedical Science
- Analytical Chemistry
- Pediatric Medicine
Background:
- Growing interest in molecular-level disease characterization for tailored therapies.
- Metabolomics as a novel field for disease phenotyping and predicting treatment response.
- Analytical platforms like mass spectrometry and NMR spectroscopy enable comprehensive metabolite analysis.
Discussion:
- Metabolic fingerprints can differentiate disease phenotypes.
- Predicting drug efficacy and toxicity through metabolic profiling.
- Application of metabolomics in pediatric clinical studies.
Key Insights:
- Metabolomics provides a detailed overview of metabolites for sample characterization.
- Non-invasive sample collection (urine, breath condensate) makes metabolomics suitable for pediatrics.
- This approach aids in identifying personal metabolic features for personalized medicine.
Outlook:
- Further exploration of metabolomic applications in pediatric disease research.
- Potential for improved diagnostics and therapeutic strategies in children.
- Advancing personalized medicine through comprehensive metabolic analysis.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...